Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
$0.80 per share
Est. EPS $5.23 · Revenue $4.72B · 11 analysts
Est. EPS $5.67 · Revenue $4.75B · 10 analysts
Est. EPS $22.51 · Revenue $18.61B · 11 analysts
$0.80 per share
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $17.4B | +9.7% | +3.2% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $1.5B | +30.4% | +2.8% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +90.4% | +0.5% | +0.4% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +11.5% | +8.1% | -0.4% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +8.6% | +18.8% | -0.4% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $849.2M | -24.4% | +16.9% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +4.9% | -31.1% | +13.3% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 75.7% | +1.8% | +2.9% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 1.05x | -17.4% | +3.4% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $16.0B | +10.3% | +1.6% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 23.10 vs 21.74 | +6.3% | 5.98 vs 5.23 | +14.4% |
| Revenue Surprise | $17.4B vs $17.4B | -0.0% | $4.6B vs $4.7B | -1.7% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| May 27, 2026 | MILLER ALAN B | director, 10 percent owner, officer: Executive Chairman | Class B Common Stock | A | 14,163 | — |
| May 27, 2026 | MILLER ALAN B | director, 10 percent owner, officer: Executive Chairman | Class B Common Stock | A | 14,163 | — |
| May 27, 2026 | MILLER ALAN B | director, 10 percent owner, officer: Executive Chairman | Class B Common Stock | A | 14,163 | — |
| May 27, 2026 | MILLER ALAN B | director, 10 percent owner, officer: Executive Chairman | Class B Common Stock | A | 9,418 | — |
| May 27, 2026 | MILLER ALAN B | director, 10 percent owner, officer: Executive Chairman | Class B Common Stock | D | 50,990 | — |
Operator: Good day, and thank you for standing by. Welcome to the Q2 2026 Universal Health Services earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised, To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker for today, Darren Lehrich. Please go ahead. Darren Lehrich: Thank you. Good morning, and welcome to Universal Health Services second quarter 2026 earnings conference call. I am Darren Lehrich, Vice President of Investor Relations. With me this morning are our President and CEO, Marc D. Miller and our Chief Financial Officer, Steve G. Filton. Marc and Steve will provide some prepared remarks and then we will open it up for Q&A. During today's conference call, we will be using words such as believes, expects, anticipates, estimates, and similar words that represent forecasts, projections and forward-looking statements. For anyone not familiar with the risks and uncertainties, inherent in these forward-looking statements, we recommend a careful reading of the section on risk factors and forward-looking statements and risk factors Form 10-K for the year ended December 31, 2025. And our Form 10-Q for the quarter ended March 31, 2026. In addition, we may reference during today's call measures such as EBITDA, adjusted EBITDA, adjusted EBITDA net of NCI, and adjusted net income attributable to UHS which are non-GAAP financial measures. Information and reconciliations of these non-GAAP financial measures to net income attributable to UHS can be found in yesterday's press release and our supplemental materials on our website. With that, let me now turn it over to Marc for some introductory remarks. Marc D. Miller: Thanks, Darren. Good morning, and thank you for joining today's call. I am pleased to share some operational and strategic highlights for the second quarter before Steve discusses financial highlights. Overall, our second quarter of 2026 featured a rebound in acute care volumes and behavioral health volumes that were consistent with recent trends. Continued expense management, and exchange trends that progressed in line with our expectations. During the quarter, we also benefited from the approval of the Florida DPP program for 2025 which was not contemplated in our original outlook. From an operational perspective, I want to highlight the investments we are making to expand capacity in the communities that we serve. We continue to see favorable demand trends across our markets, supporting confidence in the long-term need for capacity in both inpatient and outpatient service lines. In our acute care and behavioral health segments. Allowing us to extend our footprint …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Marc D. Miller | Chief Executive Officer, President & Director | USD 6,064,664 | Male | 1971 | Active |
Alan Miller | Founder & Executive Chairman of the Board | USD 3,011,093 | Male | 1938 | Active |
Steve G. Filton | Executive Vice President, Chief Financial Officer & Secretary | USD 2,607,084 | Male | 1958 | Active |
Edward H. Sim | Executive Vice President & President of Acute Care Division | USD 2,426,108 | Male | 1972 | Active |
Darren Lehrich | Vice President of Investor Relations | — | Male | 1972 | Active |
Jim Clark | Senior Vice President of Finance - Acute Care Division | — | Male | — | Active |
Matthew David Klein | Senior Vice President & General Counsel | — | Male | — | Active |
Michael S. Nelson | Senior Vice President of Strategic Services | — | Male | — | Active |
Maria Zangardi | Senior Vice President of Human Resources & Corporate Officer | — | Female | — | Active |
Thomas Day | Senior Vice President of Finance - Behavioral Health Division | — | — | — | Active |
NEW YORK--(BUSINESS WIRE)-- #HAEclassaction--UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services' Directors and Officers.
Investors need to pay close attention to UHS stock based on the movements in the options market lately.
I am initiating coverage on Universal Health Services with a Buy rating and a 24-month investment horizon, citing attractive valuations. UHS's behavioral health segment offers robust EBITDA margins and geographic diversification, with growth potential from the Talkspace acquisition and UK expansion. Despite concerns from the OBBBA and recent earnings misses, UHS's strong credit profile, healthy cash flows, and low leverage support continued capital allocation flexibility.
First Trust Advisors LP decreased its stake in Universal Health Services, Inc. (NYSE: UHS) by 8.3% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 174,680 shares of the health services provider's stock after selling 15,819 shares during the
On July 28, 2026, Universal Health Services Inc (UHS) shares rose 4.3% to $166.22, showing a notable rebound over recent weeks. The stock has fluctuated within
